Platelet secretion: From haemostasis to wound healing and beyond

Blood Reviews

Volumn 29, Issue 3, 2015, Pages 153-162

  Golebiewska, Ewelina M ^a   Poole, Alastair W ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Cancer metastasis; Haemostasis; Inflammation; Platelets; Secretion; SNARE proteins; Thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; CD36 ANTIGEN; FIBRINOGEN; POLYPHOSPHATE; SNARE PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBOSPONDIN; VON WILLEBRAND FACTOR;

ALPHA GRANULE; ARTICLE; BLOOD CLOTTING; CELL GRANULE; CELLULAR DISTRIBUTION; CELLULAR SECRETION; DENSE GRANULE; DISEASE ASSOCIATION; HEMOSTASIS; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; TISSUE REGENERATION; WOUND HEALING; ANIMAL; BLOOD; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; INFLAMMATION; NEOPLASMS; PLATELET ACTIVATION; WOUND HEALING;

EID: 84929319009     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2014.10.003     Document Type: Article

References (130)

1. Coller B.S. Historical perspective and future directions in platelet research. J Thromb Haemost 2011, 9(Suppl. 1):374-395.
2. Rumbaut R.E., Thiagarajan P. Platelet-vessel wall interactions in hemostasis and thrombosis. Integrated systems physiology: from molecule to function to disease. San Rafael (CA) 2010.
3. Duckers C., Simioni P., Spiezia L., Radu C., Dabrilli P., Gavasso S., et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood 2010, 115(4):879-886.
4. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103(6):2096-2104.
5. Gosk-Bierska I., McBane R.D., Wu Y., Mruk J., Tafur A., McLeod T., et al. Platelet factor XIII gene expression and embolic propensity in atrial fibrillation. Thromb Haemost 2011, 106(1):75-82.
6. Ghosh S., Shukla D., Suman K., Lakshmi B.J., Manorama R., Kumar S., et al. Inositol hexakisphosphate kinase 1 maintains hemostasis in mice by regulating platelet polyphosphate levels. Blood 2013, 122(8):1478-1486.
7. Morrissey J.H., Choi S.H., Smith S.A. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012, 119(25):5972-5979.
8. Maynard D.M., Heijnen H.F.G., Horne M.K., White J.G., Gahl W.A. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007, 5(9):1945-1955.
9. Meyers K.M., Holmsen H., Seachord C.L. Comparative study of platelet dense granule constituents. Am J Physiol 1982, 243(3):R454-R461.
10. Jonnalagadda D., Izu L.T., Whiteheart S.W. Platelet secretion is kinetically heterogeneous in an agonist-responsive manner. Blood 2012, 120(26):5209-5216.
11. Andre P., Delaney S.M., LaRocca T., Vincent D., DeGuzman F., Jurek M., et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003, 112(3):398-406.
12. Ren Q., Wimmer C., Chicka M.C., Ye S., Ren Y., Hughson F.M., et al. Munc13-4 is a limiting factor in the pathway required for platelet granule release and hemostasis. Blood 2010, 116(6):869-877.
13. Savage J.S., Williams C.M., Konopatskaya O., Hers I., Harper M.T., Poole A.W. Munc13-4 is critical for thrombosis through regulating release of ADP from platelets. J Thromb Haemost 2013, 11(4):771-775.
14. Stegner D., Deppermann C., Kraft P., Morowski M., Kleinschnitz C., Stoll G., et al. Munc13-4-mediated secretion is essential for infarct progression but not intracranial hemostasis in acute stroke. J Thromb Haemost 2013, 11(7):1430-1433.
15. van der Meijden P.E., Feijge M.A., Giesen P.L., Huijberts M., van Raak L.P., Heemskerk J.W. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk. Thromb Haemost 2005, 93(6):1128-1136.
16. Nesbitt W.S., Westein E., Tovar-Lopez F.J., Tolouei E., Mitchell A., Fu J., et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009, 15(6):665-673.
17. Maxwell M.J., Westein E., Nesbitt W.S., Giuliano S., Dopheide S.M., Jackson S.P. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood 2007, 109(2):566-576.
18. Hechler B., Nonne C., Eckly A., Magnenat S., Rinckel J.Y., Denis C.V., et al. Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization. J Thromb Haemost 2010, 8(1):173-184.
19. Stalker T.J., Traxler E.A., Wu J., Wannemacher K.M., Cermignano S.L., Voronov R., et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 2013, 121(10):1875-1885.
20. Welsh J.D., Colace T.V., Muthard R.W., Stalker T.J., Brass L.F., Diamond S.L. Platelet-targeting sensor reveals thrombin gradients within blood clots forming in microfluidic assays and in mouse. J Thromb Haemost 2012, 10(11):2344-2353.
21. Pudusseri A., Shameem R., Spyropoulos A.C. A new paradigm shift in antithrombotic therapy. Front Pharmacol 2013, 4:133.
22. Becker R.C., Bassand J.P., Budaj A., Wojdyla D.M., James S.K., Cornel J.H., et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 2011, 32(23):2933-2944.
23. Wang X., Schroder H.C., Schlossmacher U., Muller W.E. Inorganic polyphosphates: biologically active biopolymers for biomedical applications. Prog Mol Subcell Biol 2013, 54:261-294.
24. Muller F., Mutch N.J., Schenk W.A., Smith S.A., Esterl L., Spronk H.M., et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009, 139(6):1143-1156.
25. Mackman N., Gruber A. Platelet polyphosphate: an endogenous activator of coagulation factor XII. J Thromb Haemost 2010, 8(5):865-867.
26. Morrissey J.H. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol 2004, 79(2):103-108.
27. Smith S.A., Mutch N.J., Baskar D., Rohloff P., Docampo R., Morrissey J.H. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A 2006, 103(4):903-908.
28. Smith S.A., Morrissey J.H. Polyphosphate enhances fibrin clot structure. Blood 2008, 112(7):2810-2816.
29. Smith S.A., Choi S.H., Collins J.N.R., Travers R.J., Cooley B.C., Morrissey J.H. Inhibition of polyphosphate as a novel strategy for preventing thrombosis and inflammation. Blood 2012, 120(26):5103-5110.
30. Jain S., Pitoc G.A., Holl E.K., Zhang Y., Borst L., Leong K.W., et al. Nucleic acid scavengers inhibit thrombosis without increasing bleeding. Proc Natl Acad Sci U S A 2012, 109(32):12938-12943.
31. Blair P., Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 2009, 23(4):177-189.
32. Kuijpers M.J., de Witt S., Nergiz-Unal R., van Kruchten R., Korporaal S.J., Verhamme P., et al. Supporting roles of platelet thrombospondin-1 and CD36 in thrombus formation on collagen. Arterioscler Thromb Vasc Biol 2014, 34(6):1187-1192.
33. Camire R.M., Kalafatis M., Cushman M., Tracy R.P., Mann K.G., Tracy P.B. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals. J Biol Chem 1995, 270(35):20794-20800.
34. Gould W.R., Silveira J.R., Tracy P.B. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 2004, 279(4):2383-2393.
35. Hu C.J., Baglia F.A., Mills D.C., Konkle B.A., Walsh P.N. Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression. Blood 1998, 91(10):3800-3807.
36. Machlus K.R., Italiano J.E. The incredible journey: from megakaryocyte development to platelet formation. J Cell Biol 2013, 201(6):785-796.
37. Ambrosio A.L., Boyle J.A., Di Pietro S.M. Mechanism of platelet dense granule biogenesis: study of cargo transport and function of Rab32 and Rab38 in a model system. Blood 2012, 120(19):4072-4081.
38. Heijnen H.F., Debili N., Vainchencker W., Breton-Gorius J., Geuze H.J., Sixma J.J. Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998, 91(7):2313-2325.
39. Huizing M., Helip-Wooley A., Westbroek W., Gunay-Aygun M., Gahl W.A. Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet 2008, 9:359-386.
40. Fontana S., Parolini S., Vermi W., Booth S., Gallo F., Donini M., et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood 2006, 107(12):4857-4864.
41. Shotelersuk V., Gahl W.A. Hermansky-Pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab 1998, 65(2):85-96.
42. Davies B.H., Tuddenham E.G. Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 1976, 45(178):219-232.
43. Nurden A.T., Freson K., Seligsohn U. Inherited platelet disorders. Haemophilia 2012, 18(Suppl. 4):154-160.
44. Nurden A.T., Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 2011, 9(Suppl. 1):76-91.
45. Masliah-Planchon J., Darnige L., Bellucci S. Molecular determinants of platelet delta storage pool deficiencies: an update. Brit J Haematol 2013, 160(1):5-11.
46. Kaplan J., De Domenico I., Ward D.M. Chediak-Higashi syndrome. Curr Opin Hematol 2008, 15(1):22-29.
47. Cullinane A.R., Schaffer A.A., Huizing M. The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic 2013, 14(7):749-766.
48. Nieuwenhuis H.K., Akkerman J.W.N., Sixma J.J. Patients with a prolonged bleeding-time and normal aggregation tests may have storage pool deficiency - studies on 106 patients. Blood 1987, 70(3):620-623.
49. Nurden A.T., Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007, 21(1):21-36.
50. Albers C.A., Cvejic A., Favier R., Bouwmans E.E., Alessi M.C., Bertone P., et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet 2011, 43(8):735-737.
51. Gunay-Aygun M., Falik-Zaccai T.C., Vilboux T., Zivony-Elboum Y., Gumruk F., Cetin M., et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet alpha-granules. Nat Genet 2011, 43(8):732-734.
52. Kahr W.H.A., Hinckley J., Li L., Schwertz H., Christensen H., Rowley J.W., et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011, 43(8):738-740.
53. Deppermann C., Cherpokova D., Nurden P., Schulz J.N., Thielmann I., Kraft P., et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013, 10.1172/JCI69210.
54. Kahr W.H., Lo R.W., Li L., Pluthero F.G., Christensen H., Ni R., et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood 2013, 122(19):3349-3358.
55. Gissen P., Johnson C.A., Morgan N.V., Stapelbroek J.M., Forshew T., Cooper W.N., et al. Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nat Genet 2004, 36(4):400-404.
56. Blavignac J., Bunimov N., Rivard G.E., Hayward C.P. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost 2011, 37(6):713-720.
57. Kahr W.H., Zheng S., Sheth P.M., Pai M., Cowie A., Bouchard M., et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001, 98(2):257-265.
58. Sudhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323(5913):474-477.
59. Golebiewska E.M., Poole A.W. Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms?. Brit J Haematol 2014, 165(2):204-216.
60. Lemons P.P., Chen D., Bernstein A.M., Bennett M.K., Whiteheart S.W. Regulated secretion in platelets: identification of elements of the platelet exocytosis machinery. Blood 1997, 90(4):1490-1500.
61. Murata Y., Yasumi T., Shirakawa R., Izawa K., Sakai H., Abe J., et al. Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc13-4 protein. Blood 2011, 118(5):1225-1230.
62. Ye S.J., Karim Z.A., Al Hawas R., Pessin J.E., Filipovich A.H., Whiteheart S.W. Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion. Blood 2012, 120(12):2484-2492.
63. Al Hawas R., Ren Q., Ye S., Karim Z.A., Filipovich A.H., Whiteheart S.W. Munc18b/STXBP2 is required for platelet secretion. Blood 2012, 120(12):2493-2500.
64. zur Stadt U., Rohr J., Seifert W., Koch F., Grieve S., Pagel J., et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 2009, 85(4):482-492.
65. Chen D., Bernstein A.M., Lemons P.P., Whiteheart S.W. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 in dense core granule release. Blood 2000, 95(3):921-929.
66. Chen D., Lemons P.P., Schraw T., Whiteheart S.W. Molecular mechanisms of platelet exocytosis: role of SNAP-23 and syntaxin 2 and 4 in lysosome release. Blood 2000, 96(5):1782-1788.
67. Karim Z.A., Zhang J., Banerjee M., Chicka M.C., Al Hawas R., Hamilton T.R., et al. IkappaB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood 2013, 121(22):4567-4574.
68. Polgar J., Lane W.S., Chung S.-H., Houng A.K., Reed G.L. Phosphorylation of SNAP-23 in activated human platelets. J Biol Chem 2003, 278(45):44369-44376.
69. Ren Q., Barber H.K., Crawford G.L., Karim Z.A., Zhao C., Choi W., et al. Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction. Mol Biol Cell 2007, 18(1):24-33.
70. Zarbock A., Polanowska-Grabowska R.K., Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007, 21(2):99-111.
71. Gleissner C.A., von Hundelshausen P., Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008, 28(11):1920-1927.
72. Xia C.Q., Kao K.J. Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. Int Immunol 2003, 15(8):1007-1015.
73. Kasper B., Brandt E., Ernst M., Petersen F. Neutrophil adhesion to endothelial cells induced by platelet factor 4 requires sequential activation of Ras, Syk, and JNK MAP kinases. Blood 2006, 107(5):1768-1775.
74. von Hundelshausen P., Koenen R.R., Sack M., Mause S.F., Adriaens W., Proudfoot A.E., et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005, 105(3):924-930.
75. Gawaz M., Langer H., May A.E. Platelets in inflammation and atherogenesis. J Clin Invest 2005, 115(12):3378-3384.
76. Duerschmied D., Suidan G.L., Demers M., Herr N., Carbo C., Brill A., et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood 2013, 121(6):1008-1015.
77. Lam F.W., Burns A.R., Smith C.W., Rumbaut R.E. Platelets enhance neutrophil transendothelial migration via P-selectin glycoprotein ligand-1. Am J Physiol Heart Circ Physiol 2011, 300(2):H468-H475.
78. Ghasemzadeh M., Kaplan Z.S., Alwis I., Schoenwaelder S.M., Ashworth K.J., Westein E., et al. The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood 2013, 121(22):4555-4566.
79. Koenen R.R., von Hundelshausen P., Nesmelova I.V., Zernecke A., Liehn E.A., Sarabi A., et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009, 15(1):97-103.
80. Thompson J., Meddens M.J., Thorig L., van Furth R. The role of bacterial adherence in the pathogenesis of infective endocarditis. Infection 1982, 10(3):196-198.
81. Tang Y.Q., Yeaman M.R., Selsted M.E. Antimicrobial peptides from human platelets. Infect Immun 2002, 70(12):6524-6533.
82. Youssefian T., Drouin A., Masse J.M., Guichard J., Cramer E.M. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002, 99(11):4021-4029.
83. Clemetson K.J. The role of platelets in defence against pathogens. Hamostaseologie 2011, 31(4):264-268.
84. Berthet J., Damien P., Hamzeh-Cognasse H., Arthaud C.A., Eyraud M.A., Zeni F., et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol 2012, 145(3):189-200.
85. Yeaman M.R. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol 2014, 12(6):426-437.
86. Li L., Blumenthal D.K., Terry C.M., He Y., Carlson M.L., Cheung A.K. PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J Cell Biochem 2011, 112(1):289-298.
87. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty - potential biologic determinants and role of intimal hyperplasia. Circulation 1989, 79(6):1374-1387.
88. Andrae J., Gallini R., Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Gene Dev 2008, 22(10):1276-1312.
89. Massberg S., Konrad I., Schurzinger K., Lorenz M., Schneider S., Zohlnhoefer D., et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006, 203(5):1221-1233.
90. Xu X., Zhu F., Zhang M., Zeng D., Luo D., Liu G., et al. Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrow-derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs 2013, 197(2):103-113.
91. + cells to endothelial progenitor cells. Circulation 2008, 117(2):206-215.
92. Bermudez D.M., Xu J., Herdrich B.J., Radu A., Mitchell M.E., Liechty K.W. Inhibition of stromal cell-derived factor-1alpha further impairs diabetic wound healing. J Vasc Surg 2011, 53(3):774-784.
93. Daub K., Langer H., Seizer P., Stellos K., May A.E., Goyal P., et al. Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells. FASEB J 2006, 20(14):2559-2561.
94. Petit I., Jin D., Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007, 28(7):299-307.
95. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104(12):3472-3482.
96. Salvucci O., Yao L., Villalba S., Sajewicz A., Pittaluga S., Tosato G. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002, 99(8):2703-2711.
97. Battinelli E.M., Markens B.A., Italiano J.E. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 2011, 118(5):1359-1369.
98. Gawaz M., Vogel S. Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. Blood 2013, 122(15):2550-2554.
99. Nurden A.T., Nurden P., Sanchez M., Andia I., Anitua E. Platelets and wound healing. Front Biosci 2008, 13:3532-3548.
100. Gasic G.J., Gasic T.B., Stewart C.C. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A 1968, 61(1):46-52.
101. Ho-Tin-Noe B., Goerge T., Cifuni S.M., Duerschmied D., Wagner D.D. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res 2008, 68(16):6851-6858.
102. Erpenbeck L., Schon M.P. Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 2010, 115(17):3427-3436.
103. Yu J.H., Ustach C., Kim H.R.C. Platelet-derived growth factor signaling and human cancer. J Biochem Mol Biol 2003, 36(1):49-59.
104. Carvalho I., Milanezi F., Martins A., Reis R.M., Schmitt F. Overexpression of platelet-derived growth factor receptor a in breast cancer is associated with tumour progression. Breast Cancer Res 2005, 7(5):R788-R795.
105. Zhang J., Wang P., Dykstra M., Gelebart P., Williams D., Ingham R., et al. Platelet-derived growth factor receptor-alpha promotes lymphatic metastases in papillary thyroid cancer. J Pathol 2012, 228(2):241-250.
106. Dvorak H.F., Detmar M., Claffey K.P., Nagy J.A., van de Water L., Senger D.R. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995, 107(1-3):233-235.
107. Goel H.L., Mercurio A.M. VEGF targets the tumour cell. Nat Rev Cancer 2013, 13(12):871-882.
108. Labelle M., Begum S., Hynes R.O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 2011, 20(5):576-590.
109. Bambace N.M., Holmes C.E. The platelet contribution to cancer progression. J Thromb Haemost 2011, 9(2):237-249.
110. Wang Z., Huang H. Platelet factor-4 (CXCL4/PF-4): an angiostatic chemokine for cancer therapy. Cancer Lett 2013, 331(2):147-153.
111. Schumacher D., Strilic B., Sivaraj K.K., Wettschureck N., Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell 2013, 24(1):130-137.
112. Harper M.T., Savage J.S., Poole A.W. Comment on "Platelet-derived nucleotides promote tumor cell transendothelial migration and metastasis via P2Y(2) receptor" by Schumacher et al. Cancer Cell 2013, 24(3):287.
113. Li Z.Y., Yang F.M.Y., Dunn S., Gross A.K., Smyth S.S. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res 2011, 127(3):184-188.
114. Nachman R.L., Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med 2008, 359(12):1261-1270.
115. Lee W.L., Slutsky A.S. Sepsis and endothelial permeability. N Engl J Med 2010, 363(7):689-691.
116. Morrell C.N., Sun H., Swaim A.M., Baldwin W.M. Platelets an inflammatory force in transplantation. Am J Transplant 2007, 7(11):2447-2454.
117. Valenzuela N.M., Hong L., Shen X.D., Gao F., Young S.H., Rozengurt E., et al. Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant 2013, 13(2):299-311.
118. Zarbock A., Ley K. The role of platelets in acute lung injury (ALI). Front Biosci (Landmark Ed) 2009, 14:150-158.
119. Grommes J., Alard J.E., Drechsler M., Wantha S., Morgelin M., Kuebler W.M., et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med 2012, 185(6):628-636.
120. McCormack G., Moriarty D., O'Donoghue D.P., McCormick P.A., Sheahan K., Baird A.W. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001, 50(10):491-495.
121. Waeber C., Moskowitz M.A. Migraine as an inflammatory disorder. Neurology 2005, 64(10):S9-S15.
122. Ulfman L.H., Joosten D.P.H., van Aalst C.W., Lammers J.W.J., van de Graaf E., Koenderman L., et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol 2003, 28(4):512-519.
123. Ma L., Perini R., McKnight W., Dicay M., Klein A., Hollenberg M.D., et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci U S A 2005, 102(1):216-220.
124. Sehgal S., Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007, 5(10):2009-2016.
125. Italiano J.E., Richardson J.L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008, 111(3):1227-1233.
126. Kamykowski J., Carlton P., Sehgal S., Storrie B. Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet alpha-granules. Blood 2011, 118(5):1370-1373.
127. van Nispen tot Pannerden H., de Haas F., Geerts W., Posthuma G., van Dijk S., Heijnen H.F. The platelet interior revisited: electron tomography reveals tubular alpha-granule subtypes. Blood 2010, 116(7):1147-1156.
128. Kreykenbohm V., Wenzel D., Antonin W., Atlachkine V., von Mollard G.F. The SNAREs vti1a and vti1b have distinct localization and SNARE complex partners. Eur J Cell Biol 2002, 81(5):273-280.
129. Mollinedo F., Calafat J., Janssen H., Martin-Martin B., Canchado J., Nabokina S.M., et al. Combinatorial SNARE complexes modulate the secretion of cytoplasmic granules in human neutrophils. J Immunol 2006, 177(5):2831-2841.
130. Morgenstern E. The pathway of exocytosis in human platelets. Blood 1998, 92(6):2191-2192.